Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · fourth_quarter · 4@
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics. S. 1871: The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.
Source: Senate LDA
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Medical Testing Availability Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Medical Testing Availability Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Medical Testing Availability Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics. S. 1871: The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics. S. 1871: The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft regulation regarding Unique Device Identification System: Provisions regarding FDA requirements for medical device labeling.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. S. 2375/H.R. 5973: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013; Provisions regarding FDA funding.
Further Additional Continuing Appropriations Amendments, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12 (No Bill Number to date); Provisions regarding National Institutes of Health funding. H.R. 1363: Department of Defense and Further Additional Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding. H.R. 1473: Department of Defense and Full Year Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding, biosurveillance programs and appropriations for forensic DNA.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Department of Homeland Security Appropriations Act, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Montgomery GI Bill Degree Extension Act of 2007
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · fourth_quarter · 4T
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics. S. 1871: The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · third_quarter · Q3
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics.
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · second_quarter · Q2
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. No bill numbers to date: BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act; Provisions regarding lab developed tests.
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate setting of certain diagnostics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · first_quarter · Q1
Draft regulation: Food Safety Modernization Act implementing regulations; Provisions regarding finished product testing.
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. No bill numbers to date: BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act; Provisions regarding lab developed tests.
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate setting for certain diagnostics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · fourth_quarter · Q4
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft regulation regarding Unique Device Identification System: Provisions regarding FDA requirements for medical device labeling.
New and Reconsidered Clinical Laboratory Fee Schedule (CLFS) Test Codes and Preliminary Payment Determinations; Provisions regarding coding for certain diagnostics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · third_quarter · Q3
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. Unique Device Identifier proposed rule; Provisions regarding date format.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · second_quarter · Q2
H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. S. 2375/H.R. 5973: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013; Provisions regarding FDA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · first_quarter · Q1
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · fourth_quarter · Q4
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. H.R. 2112: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012; Provisions regarding FDA funding.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · third_quarter · Q3
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12; Provisions regarding National Institutes of Health funding. H.R. 2112: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012; Provisions regarding FDA funding.
Regulation regarding Shiga Toxin-Producing Escherichia coli in Certain Raw Beef Products; Provisions regarding testing requirements.
BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · second_quarter · Q2
Synthetic Biology Research and Advancement Act (No bill number to date); Provisions regarding DNA synthesizer certification.
BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests.
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12 (No Bill Number to date); Provisions regarding National Institutes of Health funding. H.R. 1363: Department of Defense and Further Additional Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding. H.R. 1473: Department of Defense and Full Year Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding, biosurveillance programs and appropriations for forensic DNA.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · first_quarter · Q1
Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, FY12 (No Bill Number to Date); Provisions regarding National Institutes of Health funding. HJRES44/HJRES48: 5th and 6th Continuing Appropriations Resolution, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding. H.R.1/S.Amdt.149: Full Year Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding; biosurveillance programs and appropriations for Forensic DNA.
BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2010 · fourth_quarter · Q4
Synthetic Biology Research and Advancement Act (No bill number to date); Provisions regarding DNA synthesizer certification.
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Regulation regarding veterinary biologics; Provisions regarding process improvements.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Synthetic Biology Research and Advancement Act (No bill number to date); Provisions regarding DNA synthesizer certification.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE